{"entity":{"type":"insider","cik":"0001632384","url":"/insider/0001632384","json_url":"/insider/0001632384.json","name":"Galante Joseph C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":465,"n_filings":30,"first":"2015-02-11","last":"2023-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Galante Joseph C","source":"filing","n_filings":30,"first_seen":"2015-02-11","last_seen":"2023-01-23"}],"transactions":[{"id":7879871,"accession":"0001567619-23-001121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-001121","line_url":"/filing/0001567619-23-001121#line-1","is_derivative":false,"issuer_cik":"0001115055","issuer_name":"PINNACLE FINANCIAL PARTNERS INC","issuer_ticker":"PNFP","issuer_name_source":null,"issuer_url":"/issuer/0001115055","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"PNFP Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":72.26,"price_display":"72.26","price_state":"stated","total_value":72260.0,"total_display":"72,260.00","total_whole":"72,260","shares_owned_after":22508.0,"shares_owned_after_display":"22,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":6400263,"accession":"0001209191-22-062651","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-15","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":180.0,"shares_display":"180","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":399.6,"total_display":"399.60","total_whole":"400","shares_owned_after":57356.0,"shares_owned_after_display":"57,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-23","scope":"insider"},{"id":6400260,"accession":"0001209191-22-062651","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-14","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":462.0,"total_display":"462.00","total_whole":"462","shares_owned_after":57176.0,"shares_owned_after_display":"57,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-23","scope":"insider"},{"id":6400258,"accession":"0001209191-22-062651","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-13","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":552.5,"total_display":"552.50","total_whole":"553","shares_owned_after":56976.0,"shares_owned_after_display":"56,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-23","scope":"insider"},{"id":6400255,"accession":"0001209191-22-062651","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-12","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":222.0,"total_display":"222.00","total_whole":"222","shares_owned_after":56726.0,"shares_owned_after_display":"56,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-23","scope":"insider"},{"id":6400254,"accession":"0001209191-22-062651","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-11","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60.0,"shares_display":"60","price_per_share":2.24,"price_display":"2.24","price_state":"stated","total_value":134.4,"total_display":"134.40","total_whole":"134","shares_owned_after":56626.0,"shares_owned_after_display":"56,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-23","scope":"insider"},{"id":6400252,"accession":"0001209191-22-062651","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-10","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120.0,"shares_display":"120","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":265.2,"total_display":"265.20","total_whole":"265","shares_owned_after":56566.0,"shares_owned_after_display":"56,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-23","scope":"insider"},{"id":6400249,"accession":"0001209191-22-062651","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-9","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120.0,"shares_display":"120","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":261.6,"total_display":"261.60","total_whole":"262","shares_owned_after":56446.0,"shares_owned_after_display":"56,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-23","scope":"insider"},{"id":6400247,"accession":"0001209191-22-062651","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":139.1,"total_display":"139.10","total_whole":"139","shares_owned_after":56326.0,"shares_owned_after_display":"56,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-23","scope":"insider"},{"id":6400244,"accession":"0001209191-22-062651","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":139.75,"total_display":"139.75","total_whole":"140","shares_owned_after":56261.0,"shares_owned_after_display":"56,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-23","scope":"insider"},{"id":6400242,"accession":"0001209191-22-062651","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":142.35,"total_display":"142.35","total_whole":"142","shares_owned_after":56196.0,"shares_owned_after_display":"56,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-23","scope":"insider"},{"id":6400239,"accession":"0001209191-22-062651","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":141.7,"total_display":"141.70","total_whole":"142","shares_owned_after":56131.0,"shares_owned_after_display":"56,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-23","scope":"insider"},{"id":6400237,"accession":"0001209191-22-062651","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":142.35,"total_display":"142.35","total_whole":"142","shares_owned_after":56066.0,"shares_owned_after_display":"56,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-23","scope":"insider"},{"id":6400234,"accession":"0001209191-22-062651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":142.35,"total_display":"142.35","total_whole":"142","shares_owned_after":56001.0,"shares_owned_after_display":"56,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-23","scope":"insider"},{"id":6400230,"accession":"0001209191-22-062651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":150.15,"total_display":"150.15","total_whole":"150","shares_owned_after":55936.0,"shares_owned_after_display":"55,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-23","scope":"insider"},{"id":6400227,"accession":"0001209191-22-062651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062651","line_url":"/filing/0001209191-22-062651#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":151.45,"total_display":"151.45","total_whole":"151","shares_owned_after":55871.0,"shares_owned_after_display":"55,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-23","scope":"insider"},{"id":6107963,"accession":"0001209191-22-062643","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-21","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":150.8,"total_display":"150.80","total_whole":"151","shares_owned_after":55806.0,"shares_owned_after_display":"55,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2022-12-23","scope":"insider"},{"id":6107960,"accession":"0001209191-22-062643","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-20","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":152.1,"total_display":"152.10","total_whole":"152","shares_owned_after":55741.0,"shares_owned_after_display":"55,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-29","filed_date":"2022-12-23","scope":"insider"},{"id":6107957,"accession":"0001209191-22-062643","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-19","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":154.05,"total_display":"154.05","total_whole":"154","shares_owned_after":55676.0,"shares_owned_after_display":"55,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-12-23","scope":"insider"},{"id":6107956,"accession":"0001209191-22-062643","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-18","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":150.15,"total_display":"150.15","total_whole":"150","shares_owned_after":55611.0,"shares_owned_after_display":"55,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-12-23","scope":"insider"},{"id":6107953,"accession":"0001209191-22-062643","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-17","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":148.85,"total_display":"148.85","total_whole":"149","shares_owned_after":55546.0,"shares_owned_after_display":"55,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-12-23","scope":"insider"},{"id":6107950,"accession":"0001209191-22-062643","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-16","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":154.05,"total_display":"154.05","total_whole":"154","shares_owned_after":55481.0,"shares_owned_after_display":"55,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-12-23","scope":"insider"},{"id":6107949,"accession":"0001209191-22-062643","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-15","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.38,"price_display":"2.38","price_state":"stated","total_value":154.7,"total_display":"154.70","total_whole":"155","shares_owned_after":55416.0,"shares_owned_after_display":"55,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-12-23","scope":"insider"},{"id":6107945,"accession":"0001209191-22-062643","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-14","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":147.55,"total_display":"147.55","total_whole":"148","shares_owned_after":55351.0,"shares_owned_after_display":"55,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-12-23","scope":"insider"},{"id":6107942,"accession":"0001209191-22-062643","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-13","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":148.85,"total_display":"148.85","total_whole":"149","shares_owned_after":55286.0,"shares_owned_after_display":"55,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-12-23","scope":"insider"},{"id":6107940,"accession":"0001209191-22-062643","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-12","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":150.15,"total_display":"150.15","total_whole":"150","shares_owned_after":55221.0,"shares_owned_after_display":"55,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-12-23","scope":"insider"},{"id":6107937,"accession":"0001209191-22-062643","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-11","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":152.75,"total_display":"152.75","total_whole":"153","shares_owned_after":55156.0,"shares_owned_after_display":"55,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-12-23","scope":"insider"},{"id":6107934,"accession":"0001209191-22-062643","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-10","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":150.8,"total_display":"150.80","total_whole":"151","shares_owned_after":55091.0,"shares_owned_after_display":"55,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-12-23","scope":"insider"},{"id":6107933,"accession":"0001209191-22-062643","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-9","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":150.8,"total_display":"150.80","total_whole":"151","shares_owned_after":55026.0,"shares_owned_after_display":"55,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-12-23","scope":"insider"},{"id":6107931,"accession":"0001209191-22-062643","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":154.05,"total_display":"154.05","total_whole":"154","shares_owned_after":54961.0,"shares_owned_after_display":"54,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-12-23","scope":"insider"},{"id":6107928,"accession":"0001209191-22-062643","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":154.05,"total_display":"154.05","total_whole":"154","shares_owned_after":54896.0,"shares_owned_after_display":"54,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-12-23","scope":"insider"},{"id":6107925,"accession":"0001209191-22-062643","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":157.3,"total_display":"157.30","total_whole":"157","shares_owned_after":54831.0,"shares_owned_after_display":"54,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-12-23","scope":"insider"},{"id":6107922,"accession":"0001209191-22-062643","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":159.25,"total_display":"159.25","total_whole":"159","shares_owned_after":54766.0,"shares_owned_after_display":"54,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-12-23","scope":"insider"},{"id":6107920,"accession":"0001209191-22-062643","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":157.3,"total_display":"157.30","total_whole":"157","shares_owned_after":54701.0,"shares_owned_after_display":"54,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-12-23","scope":"insider"},{"id":6107913,"accession":"0001209191-22-062643","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":158.6,"total_display":"158.60","total_whole":"159","shares_owned_after":54636.0,"shares_owned_after_display":"54,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-12-23","scope":"insider"},{"id":6107910,"accession":"0001209191-22-062643","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.54,"price_display":"2.54","price_state":"stated","total_value":165.1,"total_display":"165.10","total_whole":"165","shares_owned_after":54571.0,"shares_owned_after_display":"54,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-12-23","scope":"insider"},{"id":6107907,"accession":"0001209191-22-062643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062643","line_url":"/filing/0001209191-22-062643#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":164.45,"total_display":"164.45","total_whole":"164","shares_owned_after":54506.0,"shares_owned_after_display":"54,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-12-23","scope":"insider"},{"id":6518466,"accession":"0001209191-22-057942","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-25","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.54,"price_display":"2.54","price_state":"stated","total_value":165.1,"total_display":"165.10","total_whole":"165","shares_owned_after":54441.0,"shares_owned_after_display":"54,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-18","scope":"insider"},{"id":6518465,"accession":"0001209191-22-057942","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-24","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":163.8,"total_display":"163.80","total_whole":"164","shares_owned_after":54376.0,"shares_owned_after_display":"54,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-11-18","scope":"insider"},{"id":6518461,"accession":"0001209191-22-057942","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-23","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":161.85,"total_display":"161.85","total_whole":"162","shares_owned_after":54311.0,"shares_owned_after_display":"54,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-11-18","scope":"insider"},{"id":6518459,"accession":"0001209191-22-057942","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-22","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":157.3,"total_display":"157.30","total_whole":"157","shares_owned_after":54246.0,"shares_owned_after_display":"54,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-11-18","scope":"insider"},{"id":6518456,"accession":"0001209191-22-057942","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-21","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":158.6,"total_display":"158.60","total_whole":"159","shares_owned_after":54181.0,"shares_owned_after_display":"54,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-11-18","scope":"insider"},{"id":6518453,"accession":"0001209191-22-057942","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-20","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.38,"price_display":"2.38","price_state":"stated","total_value":154.7,"total_display":"154.70","total_whole":"155","shares_owned_after":54116.0,"shares_owned_after_display":"54,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-11-18","scope":"insider"},{"id":6518452,"accession":"0001209191-22-057942","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-19","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":161.85,"total_display":"161.85","total_whole":"162","shares_owned_after":54051.0,"shares_owned_after_display":"54,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-11-18","scope":"insider"},{"id":6518447,"accession":"0001209191-22-057942","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-18","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":158.6,"total_display":"158.60","total_whole":"159","shares_owned_after":53986.0,"shares_owned_after_display":"53,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-11-18","scope":"insider"},{"id":6518444,"accession":"0001209191-22-057942","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-17","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":157.3,"total_display":"157.30","total_whole":"157","shares_owned_after":53921.0,"shares_owned_after_display":"53,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-11-18","scope":"insider"},{"id":6518441,"accession":"0001209191-22-057942","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-16","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":159.9,"total_display":"159.90","total_whole":"160","shares_owned_after":53856.0,"shares_owned_after_display":"53,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-11-18","scope":"insider"},{"id":6518438,"accession":"0001209191-22-057942","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-15","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":151.45,"total_display":"151.45","total_whole":"151","shares_owned_after":53791.0,"shares_owned_after_display":"53,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-11-18","scope":"insider"},{"id":6518435,"accession":"0001209191-22-057942","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-14","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":150.15,"total_display":"150.15","total_whole":"150","shares_owned_after":53726.0,"shares_owned_after_display":"53,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-11-18","scope":"insider"},{"id":6518429,"accession":"0001209191-22-057942","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-22-057942","line_url":"/filing/0001209191-22-057942#line-13","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001632384","owner_name":"Galante Joseph C","owner_display_name":"Galante Joseph C","owner_url":"/insider/0001632384","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65.0,"shares_display":"65","price_per_share":2.38,"price_display":"2.38","price_state":"stated","total_value":154.7,"total_display":"154.70","total_whole":"155","shares_owned_after":53661.0,"shares_owned_after_display":"53,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-11-18","scope":"insider"}],"collapsed":true,"next_cursor":"2022-10-13|6518429","ledger_fault":false,"count":{"value":465,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":464,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":465},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001115055","name":"PINNACLE FINANCIAL PARTNERS INC","url":"/issuer/0001115055","role":"Director","n_filings":7,"first_seen":"2017-05-18","last_seen":"2023-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001087294","name":"CUMBERLAND PHARMACEUTICALS INC","url":"/issuer/0001087294","role":"Director","n_filings":22,"first_seen":"2019-04-12","last_seen":"2022-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001616297","name":"Avenue Financial Holdings, Inc.","url":"/issuer/0001616297","role":"Director","n_filings":1,"first_seen":"2015-02-11","last_seen":"2015-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001632384","retrieved_at":"2026-08-23T04:01:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}